Coherus BioSciences Completes Asset Acquisition
Ticker: CHRS · Form: 8-K · Filed: Apr 14, 2025 · CIK: 1512762
Sentiment: neutral
Topics: acquisition, assets, intellectual-property
TL;DR
Coherus just bought assets from Organon, expanding their biz.
AI Summary
On April 11, 2025, Coherus BioSciences, Inc. announced the completion of its acquisition of certain assets from Organon & Co. This transaction involves the transfer of specific intellectual property and related assets, marking a significant step in Coherus's strategic growth. The filing does not disclose specific financial terms for this asset acquisition.
Why It Matters
This acquisition could expand Coherus BioSciences' product portfolio and market presence, potentially leading to future revenue growth and increased competition in its therapeutic areas.
Risk Assessment
Risk Level: medium — The acquisition of assets carries inherent risks related to integration, market acceptance, and potential future regulatory hurdles, which could impact Coherus's financial performance.
Key Players & Entities
- Coherus BioSciences, Inc. (company) — Registrant
- Organon & Co. (company) — Seller of acquired assets
- Delaware (jurisdiction) — State of incorporation
- April 11, 2025 (date) — Date of earliest event reported
FAQ
What specific assets were acquired from Organon & Co. by Coherus BioSciences?
The filing states that Coherus BioSciences acquired 'certain assets' from Organon & Co., including intellectual property and related assets, but does not specify the exact nature or list of these assets.
What was the financial consideration for this asset acquisition?
The filing does not disclose the specific dollar amount or financial terms of the asset acquisition from Organon & Co.
When did the acquisition of assets from Organon & Co. officially complete?
The acquisition of certain assets from Organon & Co. was completed on April 11, 2025.
What is the primary business of Coherus BioSciences, Inc. according to the filing?
Coherus BioSciences, Inc. is in the business of Biological Products (No Diagnostic Substances), as indicated by its Standard Industrial Classification code [2836].
What is the former name of Coherus BioSciences, Inc. and when did the name change occur?
The former name of Coherus BioSciences, Inc. was BioGenerics, Inc., and the date of the name change was February 10, 2011.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 14, 2025 regarding Coherus BioSciences, Inc. (CHRS).